Hormonal and biochemical changes during treatment of endometriosis with the luteinizing hormone-releasing hormone (LH-RH) agonist [D-Trp6,des-Gly-NH2(10)]LH-RH ethylamide

Dupont A, André Dupont, A Dupont, Dupont P, P Dupont, Pierre Dupont, A Belanger, Alain Bélanger, Belanger A, Mailoux J, Jacques Mailoux, J Mailoux, Cusan L, L Cusan, Léonello Cusan, Labrie F, Fernand Labrie, F Labrie
Fertility and sterility · 1990 · vol. 54(2) , pp. 227–232 · doi:10.1016/s0015-0282(16)53694-2 · PMID:2199228 · W2399593562
Non-randomised trial OA: closed CC0 ⤵ 9 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study investigated hormonal and biochemical alterations in women with endometriosis undergoing treatment with the LH-RH agonist [D-Trp6, des-Gly-NH210]LH-RH ethylamide.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The effect of medical oophorectomy induced by treatment with the luteinizing hormone-releasing hormone (LH-RH) agonist [D-Trp6,des-Gly-NH2(10)]LH-RH ethylamide was studied in 34 patients with laparoscopically proven endometriosis. Tamoxifen was administered during the 1st month of therapy to prevent flare-up of the disease during the estrogen surge. Fifteen women had a decrease of their laparoscopy scores translated into an improvement in the stage of disease, whereas in 12 others, the decrease in their scores was not enough to allow a change of disease stage. The 2nd laparoscopy was not performed in 7 women. Medical oophorectomy, after daily injection of the LH-RH agonist (LH-RH-a), was accompanied by low levels of circulating estradiol. The serum concentration of all delta 4-3-ketosteroids was significantly decreased during medical oophorectomy, whereas the level of circulating delta 5-3 beta-hydroxysteroids was not altered except for pregnenolone. The present data indicate that medical oophorectomy induced by an LH-RH-a in association with tamoxifen is a very efficient and well tolerated therapy in endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Adrenal Cortex Hormones Endometriosis Gonadal Steroid Hormones Gonadotropin-Releasing Hormone Triptorelin Pamoate Triptorelin Pamoate Triptorelin Pamoate Adrenal Cortex Hormones Adrenal Cortex Hormones Adult Adult Endometriosis Endometriosis Endometriosis Endometriosis Female Female Gonadal Steroid Hormones Gonadal Steroid Hormones Gonadotropin-Releasing Hormone

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (27)

Cited by (9)

Source provenance

europepmc
last seen: 2026-10-10T06:11:15.153948+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:09:27.188120+00:00
unpaywall
last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0 · commercial use OK